At CD BioGlyco, we are deeply involved in the field of glycomics and provide Glycoinformatics-assisted Glycomics Analysis Services, which is a comprehensive service that integrates glycan chain analysis and information mining. Under this service framework, we further refine the scope of services and establish Glycoinformatics-assisted Disease Glycomics Analysis Services, which focus on the analysis of disease-related glycan chain changes to reveal the unique role of glycosylation in the disease process. At the forefront of this service branch, Glycoinformatics-assisted Cancer Glycomics Analysis Services is our highlight, which focuses on the in-depth analysis of cancer glycomics.
Aberrant O-linked glycosylation is a hallmark of many cancers and can affect tumor progression, metastasis, and immune evasion. Therefore, analyzing O-linked glycans is pivotal for understanding cancer biology.
Our protocols are continuously optimized to ensure sample integrity and purity, accommodating a wide range of biological materials such as cell lines, tissue biopsies, and serum samples.
Protein extraction: We lyse cells or tissues to extract glycoproteins.
Protein enrichment and Isolation: We use affinity chromatography and precipitation methods to isolate glycoproteins.
Proteolytic digestion: We perform enzymatic digestion of proteins to release O-linked glycans.
To ensure precise and detailed glycan analysis, we employ advanced glycoengineering techniques.
Enzymatic treatment: Specific glycosidases are used to release O-linked glycans.
Glycan labeling: We label glycans with fluorescent or mass tags to enhance detection sensitivity and accuracy.
Enrichment and purification: We use lectin affinity chromatography and solid phase extraction to enrich and purify O-linked glycans.
Our advanced analytical techniques allow for comprehensive glycan analysis.
Mass spectrometry (MS): High-resolution MS provides a detailed mass profile of glycans, while Tandem MS (MS/MS) provides structural information.
Liquid chromatography (LC): We use LC in combination with MS for the analysis of complex glycan mixtures.
Capillary electrophoresis (CE): CE ensures fast and efficient glycan separation.
Glycoinformatics integrates glycan data with bioinformatics tools to perform multidimensional analysis.
Data processing and analysis: We use custom software for peak detection, glycan identification, and structural annotation.
Database integration: We cross-reference glycan data with databases such as GlyTouCan and UniCarbKB for comprehensive glycan characterization.
Network analysis: We map glycan structures to biological pathways and networks to elucidate their roles in cancer biology.
Our services culminate in a thorough interpretation of the analyzed data.
Consultative support: Clients can have one-on-one consultations with our experts to discuss findings, answer questions, and plan the next steps for research.
Comprehensive reporting: Detailed reports include glycan profiles, structural information, and quantitative data, as well as high-quality visualizations such as glycan maps and pathway diagrams.
Journal: International Journal of Molecular Sciences
IF: 4.9
Published: 2020
Results: The authors discussed how cancer glycosylation modifications involve alterations in glycan length, typically resulting in shorter O-glycans and more branched N-glycans. They noted that these glycosylation changes are often associated with significant variations in glycan sialylation and pyrophosphorylation, which impact terminal epitopes. Additionally, the authors provided an overview of various bioinformatics resources available for analyzing O-glycans. The intent of their article was to encourage collaboration between glycoinformatics scientists and cancer biologists to leverage existing glycoinformatics tools for cancer research.
Fig.1 Flowchart of glycosylation research. (Muthu, et al., 2020)
At CD BioGlyco, we aim to advance our understanding of cancer biology by providing a comprehensive analysis of O-linked glycans in cancer. Through innovation and expertise, we are committed to supporting researchers in combating cancer more effectively. Please feel free to contact us if you are interested in our analysis of O-linked glycans in cancer.
Reference
We envision a future where the intricate world of carbohydrate is no longer shrouded in mystery, but rather illuminated by the power of cutting-edge computational tools.